Literature DB >> 3471027

Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes.

A E Pontiroli, A Calderara, L Bonisolli, P Maffi, A De Pasqua, A Margonato, G Radaelli, G Gallus, G Pozza.   

Abstract

The genetic background seems to be involved in the development of type I diabetes and it might also be involved in the development of diabetic complications, but studies carried out so far have yielded conflicting results. The aim of this study was to evaluate the influence of some genetic markers and metabolic factors in the development of late diabetic complications. One hundred and twenty-seven patients (69 males, 58 females) with type I diabetes were evaluated for ABO and Rh blood groups, chlorpropamide alcohol flush (CPAF) and acetylator phenotype (AP) as well as for life-habits (smoking, alcohol use, diet and drug compliance), metabolic indexes (M-value, HbA1, cholesterol and triglyceride levels) and late complications of diabetes [coronary heart disease (CHD), arterial hypertension (AH), retinopathy and nephropathy]. Diabetic patients were more frequently fast acetylators and CPAF positive than controls and CPAF was more frequent among females than among males. None of the genetic markers used in this study appeared as a risk factor for the development of diabetic complications. At multiple logistic analysis different risk factors appeared for each microangiopathic complication. For retinopathy: female sex, duration of disease and triglyceride levels; for nephropathy: male sex, cholesterol levels and hypertension. These risk factors have already been recognized in previous studies, while the genetic markers evaluated in our study do not identify a greater or smaller risk for the development of late complications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3471027     DOI: 10.1007/BF02582069

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  61 in total

1.  Chlorpropamide alcohol flushing and diabetic retinopathy.

Authors:  R D Leslie; A H Barnett; D A Pyke
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

2.  Chlorpropamide-alcohol flushing and coronary heart disease in non-insulin dependent diabetics.

Authors:  M Laakso; K Nuorva; A Aro; M Uusitupa; O Siitonen; R Huupponen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

3.  Chlorpropamide-alcohol flushing in relation to macroangiopathy and peripheral neuropathy in non-insulin dependent diabetes.

Authors:  P Jerntorp; L O Almér
Journal:  Acta Med Scand Suppl       Date:  1981

4.  HLA phenotypes and diabetic retinopathy.

Authors:  E Möller; B Persson; G Sterky
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

5.  HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes.

Authors:  R S Gray; I R Starkey; S Rainbow; A B Kurtz; A Abdel-Khalik; S Urbaniak; R A Elton; L J Duncan; B F Clarke
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

6.  Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables.

Authors:  T A Welborn; M Knuiman; V McCann; K Stanton; I J Constable
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

7.  Hepatic acetylator phenotype in diabetes mellitus.

Authors:  J M Ladero; A Arrojo; R E de Salamanca; M Gomez; F Cano; M Alfonso
Journal:  Ann Clin Res       Date:  1982-08

8.  Association between chlorpropamide-alcohol flushing and fast acetylator phenotype in type I and type II diabetes.

Authors:  L Bonisolli; A E Pontiroli; A De Pasqua; A Calderara; P Maffi; G Gallus; G Radaelli; G Pozza
Journal:  Acta Diabetol Lat       Date:  1985 Oct-Dec

9.  Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.

Authors:  T B Vree; W J O'Reilly; Y A Hekster; J E Damsma; E van der Kleijn
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

10.  Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study.

Authors:  W Burger; G Hövener; R Düsterhus; R Hartmann; B Weber
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

View more
  4 in total

1.  Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

Authors:  C M Barbagallo; M R Averna; S Amato; G Marino; M Labisi; A C Rao; M Barbagallo; G F Cupidi; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

2.  Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.

Authors:  U J Schauer; D Pissarek; G Panzram
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

3.  Lipoprotein pattern in long-term diabetes of an at least 35 years' duration. Results of the Erfurt Study.

Authors:  U J Schauer; G Panzram; D Pissarek; K Rühling; L Winkler; R Lundershausen
Journal:  Klin Wochenschr       Date:  1988-08-01

4.  Acetylator phenotypes in diabetes mellitus.

Authors:  D Stryjek-Kamińska; B Malczewski; A Kopeć; K Rowińska-Marcińska
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.